PIK3CG expression
|
SCCHN
|
PIK3CG expression
|
SCCHN
|
duvelisib Sensitive: D – Preclinical
|
duvelisib Sensitive: D – Preclinical
|
PIK3CG expression
|
Melanoma
|
PIK3CG expression
|
Melanoma
|
duvelisib Sensitive: D – Preclinical
|
duvelisib Sensitive: D – Preclinical
|
PIK3CG expression
|
Mantle Cell Lymphoma
|
PIK3CG expression
|
Mantle Cell Lymphoma
|
copanlisib Sensitive: D – Preclinical
|
copanlisib Sensitive: D – Preclinical
|
PIK3CG expression
|
Mantle Cell Lymphoma
|
PIK3CG expression
|
Mantle Cell Lymphoma
|
BI 6727 Sensitive: D – Preclinical
|
BI 6727 Sensitive: D – Preclinical
|
PIK3CG expression
|
Mantle Cell Lymphoma
|
PIK3CG expression
|
Mantle Cell Lymphoma
|
copanlisib + BI 6727 Sensitive: D – Preclinical
|
copanlisib + BI 6727 Sensitive: D – Preclinical
|